Заранее благодарю!
1. Adv. Drug Deliv. Rev. 2013, 65, 1803-1815.
Pelgrift R. Y., Friedman A. J.
Nanotechnology as a therapeutic tool to combat microbial resistance.
- DOI:
http://dx.doi.org/10.1016/j.addr.2013.07.011
King M., Kumar P., Michel D., Batta R., Foldvari M.
In vivo sustained dermal delivery and pharmacokinetics of interferon alpha in biphasic vesicles after topical application.
- DOI:
http://dx.doi.org/10.1016/j.ejpb.2013.01.014
Shen B., Shen C., Yuan X., Bai J., Lv Q., Xu H., Dai L., Yu C., Han J., Yuan H.
Development and characterization of an orodispersible film containing drug nanoparticles.
- DOI:
http://dx.doi.org/10.1016/j.ejpb.2013.09.019
Guo J., Yue P., Lv J., Han J., Fu S., Jin S., Jin S., Yuan H.
Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension.
- DOI:
http://dx.doi.org/10.1016/j.ijpharm.2012.11.039